UK markets closed

Avivagen Inc. (VIVXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0012-0.0052 (-81.25%)
At close: 03:12PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/10/2022
31/10/2021
31/10/2020
31/10/2019
Cash flows from operating activities
Net income
-6,066
-6,066
-6,394
-4,751
-4,836
Depreciation & amortisation
87.499
87.499
124.774
127.493
4.636
Stock-based compensation
151.619
151.619
326.815
318.804
317.904
Change in working capital
1,547
1,547
-918.481
-255.445
-1.7
Inventory
219.527
219.527
-826.01
45.751
-16.607
Other working capital
-3,117
-3,117
-4,608
-3,380
-3,631
Other non-cash items
1,058
1,058
2,121
1,088
993.511
Net cash provided by operating activities
-3,117
-3,117
-4,599
-3,336
-3,522
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-8.707
-44.295
-109.204
Net cash used for investing activities
0
0
-8.707
-44.295
-109.204
Cash flows from financing activities
Debt repayment
-5,582
-5,582
-1,229
-64.185
-2,035
Common stock issued
4,029
4,029
7,500
3,000
1,076
Dividends paid
0
0
0
0
0
Other financing activities
-513.08
-513.08
-732.671
-186.472
-444.078
Net cash used provided by (used for) financing activities
1,999
1,999
5,347
2,961
2,510
Net change in cash
-1,117
-1,117
739.375
-418.627
-1,121
Cash at beginning of period
1,408
1,408
664.169
1,086
2,207
Cash at end of period
290.458
290.458
1,408
664.169
1,086
Free cash flow
Operating cash flow
-3,117
-3,117
-4,599
-3,336
-3,522
Capital expenditure
-
-
-8.707
-44.295
-109.204
Free cash flow
-3,117
-3,117
-4,608
-3,380
-3,631